| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.002 | 0.9 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.0043 | 1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |